Archives: Portfolio
64x Bio is engineering cell lines to address critical challenges in gene therapy manufacturing.
908 Devices makes handheld and desktop mass spectrometry devices to enable lab analysis wherever and whenever it’s needed.
Ansa Biotechnologies is building a next-generation, enzyme-based approach to DNA synthesis that accelerates synthetic biology research.
Aro combines advances in protein engineering, nucleic acid chemistry, and disease gene biology to achieve cell-specific oligonucleotide delivery.
CAMP4 is a preclinical biotech company pioneering the field of upregulation to restore healthy gene expression in diseased cells by programmable modulation of a new class of RNA called regRNA.
Candel is a late stage clinical biotechnology company developing oncolytic viral immunotherapies for the treatment of high unmet need cancers such as prostate and glioblastoma.
ChromaCode expands the number of samples a lab can process when using the same equipment and lab technicians, without sacrificing accuracy.
Code Bio is pioneering the development of targeted, non-viral medicines to treat and potentially cure serious and life-threatening diseases.
Culture helps scientists accelerate bioprocess development with its high-throughput bioreactor cloud lab.
Curie.Bio helps founders launch successful therapeutics companies by serving as their drug discovery copilot and seed investor.
Current Health is an enterprise remote care management platform enabling early, preventive health care at home to improve health outcomes and reduce the cost of care.
Deep Lens enables care teams to find the best available clinical trials for a patient’s specific diagnosis – at the time of diagnosis.
Delfi Diagnostics detects cancer sooner, enabling the most informed treatment decision.
DICE enables the convenience of an oral medicine with the efficacy of existing biologics to create new medicines for patients suffering from debilitating autoimmune diseases.
DNAnexus is a secure cloud platform and global network for scientific collaboration to support accelerating discoveries in genomic, multiomic, and precision medicine.
Eleanor Health is the first evidence-based, whole-person care model for individuals and populations with substance use disorders and mental health needs.
Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Emulate is pioneering organ-on-a-chip technology and enabling laboratory simulation of the human response to medicines, chemicals, and foods.
Encodia enables researchers to probe the immense complexities of the proteome routinely at a scale and resolution that was previously unattainable.
EnPlusOne is manufacturing the RNA medicines of the future.
Faro Health simplifies the design and authoring of complex clinical trials by harnessing the power of smart digital protocols.
Garuda Therapeutics is creating off-the-shelf blood stem cell therapies to provide accessible, tailored alternatives for all patients in need.
General Inception partners with inventors to ignite innovation and support their journey from inception to market.
Hawthorne Health is making clinical trials accessible and convenient for everyone, everywhere.
Incendia Therapeutics is reimagining the tumor microenvironment by creating anti-cancer therapies that lead to more effective treatment.
Inflammatix develops rapid tests to read a patient’s immune system to better characterize diseases, such as sepsis and fever of unknown origin.
Intabio provides drug producers a rapid system to confirm their batches of drugs are meeting high-quality standards.
Isolation Bio enables access to the living microbiome at unprecedented scale, enabling scientists to uncover deeper insights.
Isolere Bio is simplifying and streamlining the purification of biotherapeutics to improve global access to important drugs.
Kytopen enables non-viral manufacturing of cell therapies in a scalable process that preserves and minimally disrupts each cell.
Kyverna is a clinical-stage cell therapy company advancing a new class of curative therapies for inflammatory and autoimmune diseases.
The Merck Digital Sciences Studio (MDSS) supports early-stage biomedical startups accelerating the adoption of AI and ML tools for drug and biomarker discovery, clinical development, and enabling IT infrastructure.
Mestag Therapeutics is targeting activated fibroblast populations to influence the immune system and create impactful new medicines.
Molecule’s marketplace and ecosystem leverages web3 technology to increase access to funding and commercialization opportunities for biotech research.
NanoView characterizes exosomes – which are how cells communicate with each other – direct from sample and without purification.
Octave is developing an integrated care management platform for multiple sclerosis (MS) and other neurodegenerative diseases.
OMass Therapeutics harnesses native mass spectrometry alongside proprietary biochemistry and custom chemistry to discover therapeutics for immunological and rare diseases.
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics targeting multiple drivers of cancer.
OPT combines computational design, automation engineering, and material science to algorithmically design and digitally manufacture superior materials.
Ori Biotech automates and scales cell and gene therapy manufacturing to reduce costs, meet rapidly growing demand, and enable patient access to lifesaving treatments.
Outcomes4Me developed an AI-powered platform to empower cancer patients to navigate their care and achieve better outcomes.
Personal Genome Diagnostics (PGDx) provides advanced cancer genome analysis to help clinicians and researchers provide more informed treatment selection, sooner.
PhenomeX is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology that will advance human health.
QbDVision is helping to digitize biopharma manufacturing with a cloud-based workspace that aims to consolidate workflow and knowledge management.
Refeyn is a research tools company whose novel technology can find and characterize single molecules in only one minute, rapidly accelerating research for new drugs.
Saama is an AI clinical analytics platform company, enabling the life sciences industry to conduct faster and safer clinical development and regulatory programs.
Scipher has built a diagnostic platform that analyzes a patient’s individual molecular data to ensure optimal therapy is prescribed.
Scitara provides laboratory-specific, cloud-based software solutions to enable scientific labs with modern lab data connectivity infrastructure and tools.
Selux is developing a rapid solution for antibiotic susceptibility testing, which affects millions of patients who suffer from infection when resistant to available antibiotics.
Sherlock is developing a molecular diagnostics platform that enables instrument-free, simple-to-operate tests that can be applied across multiple diseases and in both clinical and non-clinical settings.
SimBioSys enables cancerous tumors to be visualized, helping predict a patient’s unique response to treatment.
Slingshot Biosciences develops synthetic cells for a range of applications in diagnostics and therapeutics.
Sound Agriculture’s dual-technology platform uses biochemistry and the natural power of plants to create a more agile and resilient food system.
SpeeDx developed a diagnostics platform, principally for infectious diseases, that provides both identification and therapeutic guidance capabilities in the same simplified workflow.
Story Health brings the specialty clinic to the home, bridging the gap between patients and providers with connected devices, virtual patient engagement, and AI-powered clinical decision support.
Syapse works with health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients.
Teckro is modernizing and simplifying clinical research to help make clinical trials more simple, accessible, and transparent.
Telesis bridges the digital and biological words to create specific genetic components that researchers need to better understand diseases and develop therapies.
Totus scalably invents covalent medicines with the potential for superior safety and efficacy.
Transition Bio is a microfluidics- and machine learning-driven company working to harness the potential of biomolecular condensates in revolutionizing drug discovery.
Triumvira is a clinical stage oncology cell therapy company developing a pipeline of novel autologous and allogeneic therapies with enhanced safety and efficacy over current approaches.
Ultivue’s immunohistochemistry platform is used in cancer research by leading biopharmaceutical companies to provide sensitive and comprehensive biomarker information that can advance promising cancer drugs to and through clinical trials.
Vestaron is dedicated to improving the safety, efficacy, and sustainability of crop protection through its development of environmentally friendly peptide-based biopesticides.
VieCure is an AI-powered platform that integrates data from oncology patients’ health records, including genomic sequencing, to generate real-time, patient-specific, actionable, and comprehensive treatment plans.
Vigil Neuroscience is the world’s first microglia-focused biotechnology company focused on treating rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain’s immune system.
Vital Bio is reimagining the status quo of lab testing through an ecosystem of diagnostic tools that enable patients to get real-time care that is accessible and empowering.
Vizgen’s multiplexed FISH technology, “MERFISH” allows researchers to profile gene expression with sub-cellular spatial resolution.
Walking Fish engineers B cells to stimulate the immune system and produce protein therapeutics for oncology, rare deficiency diseases, autoimmune diseases, and more.